EIF2AK3 and Miyoshi myopathy: Given the anti-MM activity of proteasome inhibitors and their importance in MM treatment in the clinic [28], we sought to evaluate the effects of PERK inhibition in MM cells in combination with BTZ, a selective and potent inhibitor of the 26S proteasome, which also induces ER stress and UPR [29,30,31,32].